Eastman Chemical Company
EMN
$77.50
$0.050.07%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.36B | 9.38B | 9.34B | 9.15B | 9.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.36B | 9.38B | 9.34B | 9.15B | 9.11B |
| Cost of Revenue | 7.03B | 7.09B | 7.14B | 7.07B | 7.04B |
| Gross Profit | 2.33B | 2.30B | 2.21B | 2.08B | 2.06B |
| SG&A Expenses | 659.00M | 664.00M | 780.00M | 760.00M | 766.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.95B | 8.00B | 8.16B | 8.06B | 8.05B |
| Operating Income | 1.42B | 1.38B | 1.19B | 1.08B | 1.06B |
| Income Before Tax | 1.12B | 1.08B | 1.21B | 1.13B | 1.11B |
| Income Tax Expenses | 191.00M | 170.00M | 318.00M | 239.00M | 180.00M |
| Earnings from Continuing Operations | 926.00 | 908.00 | 888.00 | 886.00 | 927.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | -3.00M | -3.00M | -3.00M | -2.00M |
| Net Income | 922.00M | 905.00M | 885.00M | 883.00M | 925.00M |
| EBIT | 1.42B | 1.38B | 1.19B | 1.08B | 1.06B |
| EBITDA | 1.92B | 1.89B | 1.68B | 1.57B | 1.55B |
| EPS Basic | 7.94 | 7.77 | 7.54 | 7.50 | 7.82 |
| Normalized Basic EPS | 6.28 | 6.06 | 5.02 | 4.37 | 4.27 |
| EPS Diluted | 7.86 | 7.68 | 7.47 | 7.43 | 7.76 |
| Normalized Diluted EPS | 6.21 | 6.00 | 4.97 | 4.34 | 4.24 |
| Average Basic Shares Outstanding | 464.50M | 466.70M | 469.10M | 471.20M | 472.70M |
| Average Diluted Shares Outstanding | 469.80M | 471.50M | 473.30M | 474.50M | 475.50M |
| Dividend Per Share | 3.28 | 3.26 | 3.24 | 3.22 | 3.20 |
| Payout Ratio | 41.21% | 41.88% | 42.82% | 42.81% | 40.76% |